메뉴 건너뛰기




Volumn 55, Issue 1, 2014, Pages 15-22

123I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: Results and perspectives of a multicenter phase III clinical trial

(23)  Cachin, Florent a,b,c   Miot Noirault, Elisabeth b,c   Gillet, Brigitte d   Isnardi, Vanina e   Labeille, Bruno e   Payoux, Pierre f   Meyer, Nicolas g   Cammilleri, Serge h   Gaudy, Caroline h   Razzouk Cadet, Micheline i   Lacour, Jean Philippe i   Granel Brocard, Florence j   Tychyj, Christelle k   Benbouzid, Fathalah l   Grange, Jean Daniel l   Baulieu, Françoise m   Kelly, Antony a   Merlin, Charles a   Mestas, Danielle a   Gachon, Françoise n   more..

b INSERM   (France)

Author keywords

Benzamide; Melanin; Melanoma staging

Indexed keywords

ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; FLUORODEOXYGLUCOSE F 18; GLUCOTEP; INTERFERON; IODINE 123; MELANIN; N (2 DIETHYLAMINOETHYL) 2 IODOBENZAMIDE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; BENZAMIDE; DIAGNOSTIC AGENT; N (2 DIETHYLAMINOETHYL) 2 IODOBENZAMIDE; N-(2-DIETHYLAMINOETHYL)-2-IODOBENZAMIDE; RADIOACTIVE IODINE;

EID: 84894809292     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.123554     Document Type: Article
Times cited : (37)

References (28)
  • 1
    • 33847220364 scopus 로고    scopus 로고
    • Melanoma biology and new targeted therapy
    • Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature. 2007;445: 851-857.
    • (2007) Nature. , vol.445 , pp. 851-857
    • Gray-Schopfer, V.1    Wellbrock, C.2    Marais, R.3
  • 2
    • 84857017872 scopus 로고    scopus 로고
    • Epidemiology of invasive cutaneous melanoma
    • MacKie RM, Hauschild A, Eggermont AM. Epidemiology of invasive cutaneous melanoma. Ann Oncol. 2009;20(suppl 6): vi1-vi7.
    • (2009) Ann Oncol. , vol.20 , Issue.SUPPL. 6
    • MacKie, R.M.1    Hauschild, A.2    Eggermont, A.M.3
  • 3
    • 84857660324 scopus 로고    scopus 로고
    • Therapy for metastatic melanoma: The past, present, and future
    • Finn L, Markovic SN, Joseph RW. Therapy for metastatic melanoma: the past, present, and future. BMC Med. 2012;10: 23.
    • (2012) BMC Med , vol.10 , pp. 23
    • Finn, L.1    Markovic, S.N.2    Joseph, R.W.3
  • 4
    • 84863116743 scopus 로고    scopus 로고
    • Survival in braf v600-mutant advanced melanoma treated with vemurafenib
    • Sosman JA, Kim KB, Schuchter L, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med. 2012;336: 707-714.
    • (2012) N Engl J Med. , vol.336 , pp. 707-714
    • Sosman, J.A.1    Kim, K.B.2    Schuchter, L.3
  • 5
    • 77954801079 scopus 로고    scopus 로고
    • Improved survival with ipilimumab in patients with metastatic melanoma
    • Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363: 711-723.
    • (2010) N Engl J Med. , vol.363 , pp. 711-723
    • Hodi, F.S.1    O'Day, S.J.2    McDermott, D.F.3
  • 8
    • 0025988354 scopus 로고
    • Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma
    • Michelot JM, Moreau MF, Labarre PG, et al. Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma. J Nucl Med. 1991;32: 1573-1580.
    • (1991) J Nucl Med. , vol.32 , pp. 1573-1580
    • Michelot, J.M.1    Moreau, M.F.2    Labarre, P.G.3
  • 9
    • 0027317379 scopus 로고
    • Phase ii scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-n-(2-diethylaminoethyl 4-iodobenzamide)
    • Michelot JM, Moreau MF, Veyre AJ, et al. Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2- diethylaminoethyl 4-iodobenzamide). J Nucl Med. 1993;34: 1260-1266.
    • (1993) J Nucl Med. , vol.34 , pp. 1260-1266
    • Michelot, J.M.1    Moreau, M.F.2    Veyre, A.J.3
  • 10
    • 0032920303 scopus 로고    scopus 로고
    • Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting
    • Labarre P, Papon J, Moreau MF, Moins N, Veyre A, Madelmont JC. Evaluation in mice of some iodinated melanoma imaging agents using cryosectioning and multi-wire proportional counting. Eur J Nucl Med. 1999;26: 494-498.
    • (1999) Eur J Nucl Med. , vol.26 , pp. 494-498
    • Labarre, P.1    Papon, J.2    Moreau, M.F.3    Moins, N.4    Veyre, A.5    Madelmont, J.C.6
  • 11
    • 18644369115 scopus 로고    scopus 로고
    • 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: A potential imaging agent for cutaneous melanoma staging
    • 123I-N-(2- diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging. Eur J Nucl Med Mol Imaging. 2002;29: 1478-1484.
    • (2002) Eur J Nucl Med Mol Imaging. , vol.29 , pp. 1478-1484
    • Moins, N.1    D'Incan, M.2    Bonafous, J.3
  • 12
    • 0029144657 scopus 로고
    • Synthesis, radiolabeling, and preliminary evaluation in mice of some (n-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents
    • Moreau MF, Michelot J, Papon J, et al. Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents. Nucl Med Biol. 1995;22: 737-747.
    • (1995) Nucl Med Biol. , vol.22 , pp. 737-747
    • Moreau, M.F.1    Michelot, J.2    Papon, J.3
  • 14
  • 15
    • 84863403429 scopus 로고    scopus 로고
    • Cost-effectiveness of adding fdg-pet or ct to the diagnostic work-up of patients with stage iii melanoma
    • Bastiaannet E, Uyl-de Groot CA, Brouwers AH, et al. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma. Ann Surg. 2012;255: 771-776.
    • (2012) Ann Surg. , vol.255 , pp. 771-776
    • Bastiaannet, E.1    Uyl-De Groot, C.A.2    Brouwers, A.H.3
  • 17
    • 77950361631 scopus 로고    scopus 로고
    • 18F-mel050, a selective probe for melanin with predominantly renal clearance
    • 18F-MEL050, a selective probe for melanin with predominantly renal clearance. J Nucl Med. 2010;51: 441-447.
    • (2010) J Nucl Med. , vol.51 , pp. 441-447
    • Denoyer, D.1    Greguric, I.2    Roselt, P.3
  • 19
    • 84901389050 scopus 로고    scopus 로고
    • 18F mel050) using pet/ct in patients with metastatic melanoma
    • Identifier, NCT01620749. Published May 27, 2012. Updated June 14, 2012. Accessed October 30
    • 18F MEL050) using PET/CT in patients with metastatic melanoma. ClinicalTrials.gov Web site. Identifier, NCT01620749. http://clinicaltrials.gov/ct2/show/study/NCT01620749. Published May 27, 2012. Updated June 14, 2012. Accessed October 30, 2013.
    • (2013) ClinicalTrials.Gov Web Site
  • 20
    • 0022498646 scopus 로고
    • Fine needle aspiration biopsy of metastatic melanoma: A morphologic analysis of 174 cases
    • Perry MD, Gore M, Seigler HF, Johnston WW. Fine needle aspiration biopsy of metastatic melanoma: a morphologic analysis of 174 cases. Acta Cytol. 1986;30: 385-396.
    • (1986) Acta Cytol. , vol.30 , pp. 385-396
    • Perry, M.D.1    Gore, M.2    Seigler, H.F.3    Johnston, W.W.4
  • 21
    • 0036844163 scopus 로고    scopus 로고
    • Cytomorphologic features of fineneedle aspiration of metastatic and recurrent melanoma
    • Saqi A, McGrath CM, Skovronsky D, Yu GH. Cytomorphologic features of fineneedle aspiration of metastatic and recurrent melanoma. Diagn Cytopathol. 2002; 27: 286-290.
    • (2002) Diagn Cytopathol. , vol.27 , pp. 286-290
    • Saqi, A.1    McGrath, C.M.2    Skovronsky, D.3    Yu, G.H.4
  • 22
    • 33745914962 scopus 로고    scopus 로고
    • Improved detection of metastatic melanoma by t2-weighted imaging
    • Gaviani P, Mullins ME, Braga TA, et al. Improved detection of metastatic melanoma by T2-weighted imaging. AJNR. 2006;27: 605-608.
    • (2006) AJNR. , vol.27 , pp. 605-608
    • Gaviani, P.1    Mullins, M.E.2    Braga, T.A.3
  • 23
    • 17144423534 scopus 로고    scopus 로고
    • Detectability of liver metastases in malignant melanoma: Prospective comparison of magnetic resonance imaging and positron emission tomography
    • Ghanem N, Altehoefer C, Högerle S, et al. Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography. Eur J Radiol. 2005;54: 264-270.
    • (2005) Eur J Radiol. , vol.54 , pp. 264-270
    • Ghanem, N.1    Altehoefer, C.2    Högerle, S.3
  • 24
    • 78650319332 scopus 로고    scopus 로고
    • Molecular probes for malignant melanoma imaging
    • Ren G, Pan Y, Cheng Z. Molecular probes for malignant melanoma imaging. Curr Pharm Biotechnol. 2010;11: 590-602.
    • (2010) Curr Pharm Biotechnol. , vol.11 , pp. 590-602
    • Ren, G.1    Pan, Y.2    Cheng, Z.3
  • 26
    • 80054696854 scopus 로고    scopus 로고
    • 177lu, 166ho, and 153sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma
    • 177Lu, 166Ho, and 153Sm radiolanthanides for the purpose of targeted radionuclide therapy of melanoma. Cancer Biother Radiopharm. 2011;26: 547-556.
    • (2011) Cancer Biother Radiopharm. , vol.26 , pp. 547-556
    • Ballard, B.1    Jiang, Z.2    Soll, C.E.3
  • 27
    • 77952844046 scopus 로고    scopus 로고
    • 131i-labeled benzamide for targeted radiotherapy of metastatic melanoma
    • 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma. Cancer Res. 2010; 70: 4045-4053.
    • (2010) Cancer Res. , vol.70 , pp. 4045-4053
    • Joyal, J.L.1    Barrett, J.A.2    Marquis, J.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.